Skip to content
Open access

A novel perspective on biomarkers of neurodegeneration and neuroinflammation in first episode psychosis: a cross-sectional study

Jul 2026 · BMC Psychiatry · Vol 26 · 0 citations · 39 references
Medicine

TL;DR

The findings reveal a unique, stage-dependent biological signature in early psychosis, differentiating FEP from both health and the chronic phase of illness, and supports the view of FEP as a distinct pathophysiological state involving dysregulated neuroinflammation, synaptic plasticity, and protein homeostasis.

Abstract

The biological distinction between first-episode psychosis (FEP) and chronic schizophrenia remains unclear. This study investigated a panel of non-canonical serum biomarkers related to neurodegeneration, neuroinflammation, and neurotrophic signaling across these clinical stages. In a cross-sectional design, serum concentrations of 18 biomarkers were measured using multiplex immunoassay in 49 FEP patients, 80 patients with chronic schizophrenia (SCH), and 80 healthy controls (CON). Principal component analysis identified two major axes (neuroinflammatory-neurotrophic and synaptic), but the distributions of diagnostic groups overlapped substantially. A distinct biomarker profile was identified in FEP, characterized by significantly lower levels of YKL-40 and BDNF, elevated NCAM-1, decreased TDP-43, and a higher frequency of detectable Aβ1‑42 compared to both SCH and CON groups. In contrast, the SCH group did not differ from CON on most of these markers. Correlation analysis revealed a dense, interconnected biomarker network in SCH, centered on MIF and BDNF, while FEP exhibited a single strong correlation between TDP-43 and YKL-40. Principal component analysis identified two major axes (neuroinflammatory-neurotrophic and synaptic) but showed substantial overlap between diagnostic groups. The findings reveal a unique, stage-dependent biological signature in early psychosis, differentiating FEP from both health and the chronic phase of illness. This supports the view of FEP as a distinct pathophysiological state involving dysregulated neuroinflammation, synaptic plasticity, and protein homeostasis, rather than merely a prodromal stage of chronic schizophrenia. Not applicable.

Read PDF

Similar papers

Open access Oct 2026

Circulating miR-1260a as a potential biomarker for First-Episode of Psychosis: a replication study in a treatment-Naïve Romanian cohort

The diagnosis of first-episode psychosis (FEP) in adolescents and young adults remains primarily clinical, often complicated by symptom overlap and the heterogeneity of psychiatric presentations. There is a critical need for non-invasive, objective biomarkers to support early diagnosis and patient stratification. This...

Ștefania-Alexandra Grosu, M. Dobre, Iulia Andreea Pelisenco et al. · 0 citations
Open access Oct 2026

Neural correlates of peripheral inflammation in individuals with first-episode schizophrenia

Elevated pro-inflammatory markers have been reported in schizophrenia, and inflammation has been found to modulate brain functional connectivity. This paper provides novel evidence on the association between striatal connectivity and inflammation in first-episode schizophrenia (FES) and its relationship with negative...

Giulia Cattarinussi, F. Sambataro, P. Lalousis et al. · 0 citations
Oct 2026

Beyond diagnostic boundaries: Evaluating neurocognitive and biomarker profiles in the psychosis spectrum based on Schneiderian first-rank symptoms.

BACKGROUND This study aimed to evaluate the neurobiological overlap and divergence between schizophrenia (SZ) and bipolar disorder (BD) subtypes. Specifically, we investigated neurotrophic factors, inflammatory markers, and cognitive functions by categorizing patients based on a lifetime history of Schneiderian first-r...

Tugay Elik, E. Öztürk, A. Cinkara et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.